本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

150.28
+0.26000.17%
成交量:48.31萬
成交額:7,281.23萬
市值:153.29億
市盈率:22.03
高:151.31
開:150.34
低:149.85
收:150.02
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:0.59
換手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.15
市盈率(LYR):32.18

資料載入中...

2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

重要事件披露

Form 8-K - Current report